OCuSoft, Inc. v. Unicon Optical Co. Ltd.

District Court, S.D. Texas·Decided June 4, 2026·No. 4:25-cv-03241·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT June 05, 2026 FOR THE SOUTHERN DISTRICT OF TEXAS Nathan Ochsner, Clerk HOUSTON DIVISION

OCUSOFT, INC., § § Plaintiffs, § v. § CIVIL ACTION NO. H-25-3241 § UNICON OPTICAL CO. LTD., § § Defendants. §

MEMORANDUM AND OPINION This dispute arises out of an alleged breach of a contract to manufacture colored contact lenses. OCuSOFT, a Texas corporation, alleges that Unicon Optical, a Taiwanese corporation, produced contact lenses that violated the quality-assurance specifications that the parties agreed to. (Docket Entry No. 1). Unicon has moved to dismiss the complaint for insufficient service of process and for failure to state a claim. (Docket Entry No. 10). After a careful review of the complaint, the motion to dismiss, the response, the reply, and the applicable law, the court denies the motion to dismiss for insufficient service of process and grants the motion to dismiss for failure to state a claim, in part with prejudice and in part without prejudice. The reasons for these rulings are set forth in detail below. I. Background Unicon Optical Co. Ltd. is a Taiwanese limited company with its principal place of business in Taiwan. (Docket Entry No. 1 ¶ 10). In September 2023, OCuSOFT, Inc. entered into a Confidentiality, Supply, and License Agreement (“Supply Agreement”) with Unicon. (Docket Entry No. 1 ¶ 6). Under the Supply Agreement, Unicon agreed to research, develop, design, manufacture, market, produce, and supply contact lenses, and OCuSOFT agreed to purchase the contact lenses for resale in the United States. (Id.). In October 2023, the parties agreed to a Private Label Quality Agreement (“Quality Agreement”). (Id.). Under the Quality Agreement, the parties agreed to comply “with Current Good Manufacturing Practices.” (Id.). OCuSOFT agreed “to retain the trademark for the contact

lenses, develop the marketing for the contact lenses, and maintain compliance with FDA regulations.” (Id.). Unicon agreed to manufacture products that “conform to the United States Federal Food, Drug and Cosmetic Act (the ‘FDCA’) and/or applicable Medical Device Quality System Regulations (QSR).” (Id. ¶ 7).1 After the parties entered into the Supply Agreement, OCuSOFT “spent over $800,000 for its first purchase of contacts and began to market lenses beginning in August of 2024.” (Id. ¶ 8). In September 2024, OCuSOFT “was alerted to complaints regarding the use of the lenses.” (Id.). “Wearers of the lenses complained of the fit of the lenses and noted that it was irritating to the eye,” and “[o]ptometrists reported edge lifting of the lenses.” (Id.). “In response to such

complaints, OCuSOFT sent the lenses to an independent lab for testing to ensure that the lenses met the specifications outlined in the Quality Agreement.” (Id.). “The laboratory tested the base curve, diameter and pH of the lenses provided.” (Id.). “The independent testing revealed that 50% of the plus (+) lenses tested were out of specification.” (Id. ¶ 9). In September 2024, “after OCuSOFT shared these results with Unicon, Unicon conducted its own independent testing that yielded results reflecting that the lenses were within the specification set out in the contract.” (Id.). OCuSOFT doubted the integrity of Unicon’s

1 The product specifications were detailed in a consulting agreement, which was not attached to OCuSOFT’s complaint. (Docket Entry No. 1-2 at Schedule A). 2 representations about the results of the investigation. (Id.). OCuSOFT notified Unicon again of its results, but Unicon did not take steps to cure the alleged defects or to change its manufacturing processes. (Id. ¶ 10). As a result, OCuSOFT sent a written demand to terminate the contract and for reimbursement of damages and expenses. (Id.). Unicon rejected the demand and countered with

a demand of its own for OCuSOFT’s alleged breach. (Id.). The parties continued to negotiate and exchange demands until February 2025, when OCuSOFT filed this lawsuit for breach of contract. (Id.). Because Unicon is a foreign entity that is not registered to conduct business in Texas, OCuSOFT served it through the Texas Secretary of State. (Docket Entry No. 7). Unicon challenges this service and whether the complaint states a claim on which relief can be granted. (Docket Entry No. 10). II. The Legal Standards A. Service of Process Federal Rule of Civil Procedure 4(h) provides that service of process on a corporation,

partnership, or association, whether foreign or domestic, may be served in a judicial district of the United States or in a foreign territory. Fed. R. Civ. P. 4(h). If service of process occurs in the United States, it must be done either according to state law or by delivering a copy of the summons and the complaint to an officer, managing or general agent, or other agent authorized by appointment or by law to receive service of process. Fed. R. Civ. P. 4(h)(1)(A), 4(h)(1)(B). If service of process takes place in a foreign country, Rule 4(h)(2) requires compliance with the methods of service listed in Rule 4(f). Fed. R. Civ. P. 4(h)(2). The rules for serving process are intended to give sufficient notice to defendants of any actions filed against them. See, e.g., 3d CHARLES A. WRIGHT & ARTHUR R. MILLER, FEDERAL

3 PRACTICE AND PROCEDURE § 1061, at 311–12 (2002) (”[Federal Rule 4] was designed to provide maximum freedom and flexibility in the procedures for giving all defendants . . . no matter where they might be located, notice of the commencement of the action.”); see also Goetz v. Synthesys Techs., Inc., 415 F.3d 481, 484 (5th Cir. 2005) (noting that the primary purpose of service requirements is to ensure defendants receive actual notice of the pendency of litigation against

Free access — add to your briefcase to read the full text and ask questions with AI

OCuSoft, Inc. v. Unicon Optical Co. Ltd., (S.D. Tex. 2026).

OCuSoft, Inc. v. Unicon Optical Co. Ltd. (OCuSoft, Inc. v. Unicon Optical Co. Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Goetz v. Synthesys Technologies, Inc.
415 F.3d 481 (Fifth Circuit, 2005)
Luv N' Care, Ltd. v. Insta-Mix, Inc.
438 F.3d 465 (Fifth Circuit, 2006)
Williams v. Colonial Bank, N.A.
199 F. App'x 399 (Fifth Circuit, 2006)
Cuvillier v. Taylor
503 F.3d 397 (Fifth Circuit, 2007)
Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Nabulsi v. H.H. Sheikh Issa Bin Zayed Al Nahyan
383 F. App'x 380 (Fifth Circuit, 2010)
Doctors Hospital 1997, L.P. v. Sambuca Houston, L.P.
154 S.W.3d 634 (Court of Appeals of Texas, 2005)
Rose v. Rose
117 S.W.3d 84 (Court of Appeals of Texas, 2003)
Mays v. Pierce
203 S.W.3d 564 (Court of Appeals of Texas, 2006)
English v. Fischer
660 S.W.2d 521 (Texas Supreme Court, 1983)
Michiana Easy Livin' Country, Inc. v. Holten
168 S.W.3d 777 (Texas Supreme Court, 2005)
B & W SUPPLY, INC. v. Beckman
305 S.W.3d 10 (Court of Appeals of Texas, 2009)
Capitol Brick, Inc. v. Fleming Manufacturing Co.
722 S.W.2d 399 (Texas Supreme Court, 1986)
Fretz Construction Co. v. Southern National Bank of Houston
626 S.W.2d 478 (Texas Supreme Court, 1982)
Max Protetch, Inc. v. Herrin
340 S.W.3d 878 (Court of Appeals of Texas, 2011)